Dr. Esteban S. Masuda is the Exec. VP of Research at Rigel Pharmaceuticals.
Dr Masuda is 59, he's been the Exec. VP of Research of Rigel Pharmaceuticals since . There are 1 older and 5 younger executives at Rigel Pharmaceuticals. The oldest executive at Rigel Pharmaceuticals is Raul R. Rodriguez, 60, who is the Pres, CEO & Director.
Esteban's mailing address filed with the SEC is RIGEL PHARMACEUTICALS, INC., 1180 VETERANS BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over 170,041,384$ worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth 7,281,949$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Ansbert Gadicke、Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of 961,207$. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth 16,552$.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: